We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Technion and Cleveland Clinic in Joint Research Initiative

By Biotechdaily staff writers
Posted on 14 Feb 2003
A joint research and education program in molecular medicine and biomedical engineering has been announced by Technion (Haifa, Israel) and The Cleveland Clinic (OH, USA). More...


The collaboration will begin with five research projects in the fields of cardiology and orthopedics. The projects will focus on tissue engineering, heart stem-cell research, and fine mechanics and sophisticated robotics in orthopedics. Technion is ranked among the world's leading science and technology universities. The Rappaport Faculty of Medicine at the Technion, focused on research education, has gained broad recognition in the fields of cardiology, neurologic diseases, stem cell research, and protein degradation.

The Cleveland Clinic integrates clinical and hospital care with research and education in a private, not-for-profit group practice. It is ranked as one of the best US hospitals. The Lerner Research Institute at The Cleveland Clinic received more than US$125 million in grants lasts year and created 113 new inventions. The Cleveland Clinic and Cleveland Clinic Florida have 1,100 full-time doctors representing more than 100 medical specialties and subspecialties.

"We already have begun discussing a fellowship program,” said Paul E. DiCorleto, Ph.D., chairman of The Cleveland Clinic Lerner Research Institute, "and we expect our research will result in innovative medical products that will benefit patients in the Untied States, Israel, and throughout the world, as well as engendering new economic growth in Haifa and Cleveland.”





Related Links:
Technion
Cleveland Clinic

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Pipette Calibration System
Artel PCS®
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.